NIH-funded research NIH-funded research

Cervical cancer prevention for women living with HIV in Kenya

Official title: KEMRI-PHRD UG1 CASCADE NETWORK UNIT: CERVICAL CANCER PREVENTION FOR WOMEN LIVING WITH HIV RESEARCH

Funded at Kenya Medical Research Institute (Kemri) · NIH-11403589 · Data updated 2026-11-12

This project brings cervical screening and same-day thermal ablation treatment to women living with HIV at selected clinics in Kiambu County.

More Cervical Cancer research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionKenya Medical Research Institute (Kemri)
NIH-funded
Lab location1 site (Nairobi City, Kenya)
Project startSeptember 19, 2023
Project endMay 31, 2027
Funding year2025
Award (this year)$43,987
NIH project number3UG1CA285132-03S1
Project IDNIH-11403589 on NIH RePORTER

Who could benefit from this research

Could help

Women living with HIV who receive care at the participating HIV clinics in Kiambu County, Kenya, and are eligible for cervical cancer screening.

Less likely to help

Women who do not attend the participating clinics or who have conditions that make thermal ablation unsafe (for example suspected invasive cancer or pregnancy) may not be eligible or benefit directly.

What this research studies

You can get cervical screening at your local HIV clinic and, if abnormal cells are found, receive a single-visit thermal ablation treatment the same day at one of the participating hospitals. The program is run by KEMRI with local health partners and is part of a network working to expand prevention services for women living with HIV. Clinic staff will be trained and services integrated with existing HIV care so prevention happens where you already get care. Your treatment and follow-up information may be used (with privacy protections) to improve delivery of these services for other women in the region.

Why it matters

Potential benefit: Could lower the chance of cervical cancer by providing timely screening and one-visit treatment within HIV clinics.

How similar studies have gone: Screen-and-treat programs using single-visit thermal ablation have shown encouraging results in low-resource settings, though optimizing delivery for women living with HIV is still being refined.

Where this research is happening

  • Kenya Medical Research Institute (Kemri)
    Nairobi City, Kenya
    Active

Researchers

  • Principal investigator: Mugo, Nelly Rwamba — Kenya Medical Research Institute (Kemri)
  • Study coordinator: Mugo, Nelly Rwamba

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.